Saturday, May 31, 2014

Top 10 Performing Companies To Own For 2015

NEW YORK (TheStreet) -- One of Thursday's worst-performing stocks on the S&P 500, Cameron International Corporation (CAM), plummeted 14.3% to $53.85 after reporting third-quarter results earlier in the day. The index ended the day up 0.33%.

Drilling equipment maker Cameron recorded earnings of 81 cents a share, missing Yahoo! Finance consensus of 83 cents. Revenue totaled $2.5 billion, less than expectations of $2.59 billion, but 13% higher than the same period last year.

"Record revenues were established this quarter in each of our Drilling & Production Systems businesses," said CEO Jack B. Moore.

Total orders rose 30% year-on-year to $3 billion and the company had a record $11.2 billion in backlog by the end of the quarter. Cameron said it expects fourth-quarter earnings between 95 cents and $1 a share, excluding charges. Analysts expected fourth-quarter earnings of $1.12 a share. TheStreet Ratings team rates Cameron International Corporation as a Buy with a ratings score of A-. The team has this to say about its recommendation: "We rate Cameron International Corporation (CAM) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income." You can view the full analysis from the report here: CAM Ratings Report

Top 10 Performing Companies To Own For 2015: Weingarten Realty Investors(WRI)

Weingarten Realty Investors operates as a real estate investment trust (REIT). The company engages in the management, acquisition, and development of real estate. It operates in two segments, Shopping Center and Industrial. The Shopping Center segment engages in the acquisition, development, and management of real estate, primarily anchored neighborhood and community shopping centers located in Texas, California, Louisiana, Arizona, Nevada, Arkansas, New Mexico, Oklahoma, Tennessee, Kansas, Colorado, Missouri, Illinois, Florida, North Carolina, Mississippi, Georgia, Utah, Kentucky, and Maine. Its customer base includes supermarkets, discount retailers, drugstores, and other retailers. The Industrial segment engages in the acquisition, development, and management of bulk warehouses and office/service centers. Its properties are located in Texas, Nevada, Georgia, Florida, California, and Tennessee. As of June 30, 2005, Weingarten Realty Investors owned or operated under long -term leases, directly or through its interest in joint ventures or partnerships, a total of 350 developed properties and 3 properties that are in various stages of development. Its properties include 294 shopping centers and 59 industrial properties. Weingarten Realty Investors qualifies as a REIT for federal income tax purposes. As a REIT, it would not be taxed on the portion of its income, which is distributed to shareholders, provided it distributes at least 90% of its taxable income. The company was founded in 1948 and is based in Houston, Texas.

Advisors' Opinion:
  • [By Marc Bastow]

    Shopping center real estate investment trust (REIT) Weingarten Realty (WRI) raised its quarterly dividend 6.6% to 32.5 cents per share, payable March 14 to shareholders of record as of March 6.
    WGI Dividend Yield: 4.32%

Top 10 Performing Companies To Own For 2015: Realogy Holdings Corp (RLGY)

Realogy Holdings Corp., incorporated on December 14, 2006, is an integrated provider of residential real estate services in the United States. The Company is the franchisor of residential real estate brokerages with some of the recognized brands in the real estate industry, the owner of United States residential real estate brokerage offices, the global provider of outsourced employee relocation services and a provider of title and settlement services. The Company's operating platform is supported by the Company's portfolio of industry franchise brokerage brands, including Century 21 , Coldwell Banker , Coldwell Banker Commercial , ERA , Sotheby's International Realty and Better Homes and Gardens Real Estate and the Company also owns and operates the Corcoran Group and CitiHabitats brands. In October 2013, Realogy Holdings Corp's Coldwell Banker Residential Real Estate LLC announced that it has acquired the assets of Coldwell Banker Cocoa Beach Realty's two offices in Cocoa Beach, Fla. In October 2013, Realogy Holdings Corp's NRT LLC announced the acquisition of Frank Howard Allen Realtors Company-owned operations in Northern California.

The Company operates in four segments: Real Estate Franchise Services (RFG), Company Owned Real Estate Brokerage Services (NRT), Relocation Services (Cartus) and Title and Settlement Services (TRG).As of December 31, 2012 , the Company's franchise systems had approximately 13,600 franchised and company owned offices and 238,900 independent sales associates operating under its franchise and brands in the United States and 101 other countries and territories around the world, which includes approximately 710 of its company owned and operated brokerage offices.

Real Estate Franchise Services

The Company is the franchisor of residential real estate brokerages in the world through its portfolio of well known brokerage brands, including Century 21 , Coldwell Banker , Coldwell Banker Commercial , ERA , Sotheby's International Realty an! d Better Homes and Gardens Real Estate. The Company derives substantially all of its real estate franchising revenues from royalty fees received under long-term (typically ten year) franchise agreements with its franchiseesThe Company's franchisees pay the Company fees for the right to operate under one of the Company's trademarks and to enjoy the benefits of the systems and business enhancing tools provided by its real estate franchise operations.

As of December 31, 2012 , the Company's real estate franchise systems had approximately 13,600 offices worldwide in 102 countries and territories, including approximately 6,100 brokerage offices in the United States and approximately 238,900 independent sales associates worldwide (which included approximately 41,300 independent sales agents working with its company owned brokerage offices) including approximately 166,000 sales associates operating under its franchise and brands in the United States, with an average tenure among United States franchisees of approximately 19 years as of December 31, 2012 .

Company Owned Real Estate Brokerage Services

The Company owns and operates the residential real estate brokerage business in the United States under the Coldwell Banker , Sotheby's International Realty , ERA , Corcoran Group and CitiHabitats brand names. The Company offers full-service residential brokerage services through approximately 710 company owned brokerage offices in more than 35 metropolitan areas of the United States. In addition, the Company participates in the mortgage process through its 49.9% ownership of PHH Home Loans LLC (PHH Home Loans), its home mortgage venture with PHH. The Company's home mortgage joint venture with PHH is the recommended provider of mortgages for the Company's real estate brokerage and relocation service customers (unless exclusivity is waived by PHH). The Company also assists landlords and tenants through property management services. In addition, as a full-service real estate br! okerage c! ompany, the Company promotes the complementary services of its relocation and title and settlement services businesses, in addition to PHH Home Loans.

Relocation Services

The Company is a global provider of outsourced employee relocation services. The Company is the provider of such services in the United States and also operates in key international relocation destinations. The Company offers a range of employee relocation services designed to manage all aspects of an employee's move to facilitate a smooth transition in what otherwise may be a complex and difficult process for the employee and employer. The Company's relocation services business serves corporations, including over 64% of the Fortune 50 companies, as well as affinity organizations such as insurance companies and credit unions that provide the Company's services to their members. During the year ended December 31, 2012, the Company assisted in over 158,000 relocations in more than 150 countries for approximately 1,500 active clients and as of December 31, 2012, its top 25 relocation clients had an average tenure of 17 years with the Company.

The Company primarily offers corporate clients employee relocation services, such as homesale assistance, including the evaluation, inspection, purchasing and selling of a transferee's home; the issuance of home equity advances to transferees permitting them to purchase a new home before selling their current home (these advances are generally guaranteed by the client); certain home management services; assistance in locating a new home; and closing on the sale of the old home, generally at the instruction of the client; expense processing, relocation policy counseling, relocation-related accounting, including international assignment compensation services, and other consulting services; arranging household goods moving services, with approximately 72,000 domestic and international shipments in 2012 , and providing support for all aspects of moving a transferee'! s househo! ld goods, including the handling of insurance and claim assistance, invoice auditing and quality control; coordinating visa and immigration support, intercultural and language training, and expatriation/repatriation counseling and destination services, and group move management services providing coordination for moves involving a number of transferees to or from a specific regional area over a short period of time.

Title and Settlement Services

The Company assists with the closing of real estate transactions by providing full-service title and settlement, which is closing and escrow services to customers, real estate companies, including its Company-owned real estate brokerage and relocation services businesses, as well as a targeted channel of financial institution clients, including PHH. In 2012, TRG was involved in the closing of approximately 194,000 transactions of which approximately 54,000 related to NRT. In addition to the Company's own title and settlement services, the Company also coordinates a nationwide network of attorneys, title agents and notaries to service financial institution clients on a national basis. The Company also serves as an underwriter of title insurance policies in connection with residential and commercial real estate transactions. As of December 31, 2012 , the Company had approximately 340 offices, approximately 200 of which are co-located within one of its company owned brokerage offices.

The Company competes with HSF Affiliates LLC, Brookfield Residential Property Services, HomeServices of America, Berkshire Hathaway HomeServices; RE/MAX International, Inc.; and Keller Williams Realty, Inc.

Advisors' Opinion:
  • [By Lisa Abramowicz]

    Drugstore chain Rite Aid Corp. (RAD) and residential property firm Realogy Corp. (RLGY) are two of the 283 junk-rated borrowers identified in March 2009 by Moody�� Investors Service as being at the highest risk of default that have since sold bonds.

  • [By Paul Ausick]

    Big Earnings Movers: Kellogg Co. (NYSE: K) is up 0.7% at $62.72 after announcing a restructuring program. CME Group Inc. (NASDAQ: CME) is down 1.2% at $73.77 after reporting earnings this morning. Realogy Holdings Corp. (NYSE: RLGY) is up 7.7% at $43.79.

5 Best Shipping Stocks To Own For 2015: Samson Oil and Gas Ltd (SSN)

Samson Oil & Gas Limited (Samson), incorporated on April 6, 1979, is engaged in exploration and development of oil and natural gas properties in the United States. Samson owns a working interest in each of its three material producing properties, through which it has entered into operating agreements with third parties under which the oil and gas are produced and sold. The Company also has 100% working interest in one exploration property and 50% to 100% in a second property. As of June 30, 2012, the Company�� properties included North Stockyard Project; State GC Oil and Gas Field, New Mexico; Davis Bintliff (Sabretooth Prospect), Brazoria County, Texas; Hawk Springs Project, Goshen County, Wyoming, and Roosevelt Project, Roosevelt County, Montana. As of June 30, 2012, the Company along with its subsidiaries produced approximately 87,956 barrels of oil and 214,463 thousand cubic feet of gas.

North Stockyard Project -Williston Basin, North Dakota

Samson has 34.5% working interest in 3,303 acres adjacent to the North Stockyard Oil Field, which is located in the Williston Basin in North Dakota and is operated by Zavanna LLC. Together with the Company�� working interest owners, it has drilled seven wells in this field, six in the Bakken formation and one in the Mission Canyon formation. During July 2012, the Harstad #1-15H well averaged 15 barrels of oil per day (BOPD). The Leonard-23H (10% working interest, 37.5% after non-consent penalty) is a Mississippian Middle Bakken Formation. In July 2011, this well averaged 46 barrels of oil per day. The Company drilled its third Bakken well in the North Stockyard Field, the Gary-24H (37% working interest). During July 2012, this well averaged 75 BOPD. It drilled its fourth Bakken well in the North Stockyard Field, the Rodney-14H (27% working interest). In July 2011, this well averaged 92 BOPD. It drilled its fifth Bakken well in the North Stockyard Field in Williams County, North Dakota, the Earl 1-13H (32% working interest). In Jul! y 2011, the well averaged 193 BOPD. In June 2011, it drilled its sixth Mississippian Bakken well in the North Stockyard field in Williams County, North Dakota, the Everett 1-15H (26% working interest). As of June 30, 2012, the North Stockyard project had net proved reserves of 598,500 barrels of oil and 757,800 thousand cubic feet (of natural gas).

State GC Oil and Gas Field, New Mexico

The State GC oil and gas field is located in Lea County, New Mexico, and covers approximately 600 acres. As of June 30, 2012, the field had two wells, the State GC#1 and State GC#2. Average daily production during the year ended June 30, 2012 from the State GC oil and gas field was approximately 43 BOPD and 37 million standard cubic feet per day. As of June 30, 2012, the State GC oil and gas field had net proved reserves of 65,500 barrels of oil and 87,300 thousand cubic feet (of natural gas).

Davis Bintliff #1 Well (Sabretooth Prospect), Brazoria County, Texas

The Davis Bintliff #1 well is operated by Davis Holdings. During the year ended June 30, 2012, this well averaged 29 BOPD and 2.61million cubic feet per day. As of June 30, 2012, the Davis Bintliff well had net proved reserves of 700 barrels of oil and 66,400 Thousand cubic feet (of natural gas).

Hawk Springs Project, Goshen County, Wyoming

The Company has 37.5%-100% working interest in Hawk Springs Project. The Spirit of America 1 replacement well, Spirit of America 2, was successfully drilled to a total depth of 10,634 feet during the fiscal year ended June 30, 2012 (fiscal 2012).

Roosevelt Project, Roosevelt County, Montana

The well was drilled to a total measured depth of 14,972 feet with the horizontal lateral remaining within the target zone for the entire lateral length. approximately 3,425 barrels of oil have been produced.

Advisors' Opinion:
  • [By James E. Brumley]

    Had Samson Oil & Gas Limited (NYSEMKT:SSN) made the late-July surge and subsequent early-August pullback and then gotten stuck in the mud again, I might not even bother taking a look at it. That's not how it happened though. Since the pullback, SSN has perked up again, perhaps not as hot as it was with the initial rally at the end of last month, but more than hot enough to get my attention. I suspect another surge - perhaps a longer-lasting surge - is in the cards.

Top 10 Performing Companies To Own For 2015: Durata Therapeutics Inc (DRTX)

Durata Therapeutics, Inc., incorporated on November 4, 2009, is a pharmaceutical company focused on the development and commercialization of therapeutics for patients with infectious diseases and acute illnesses. The Company enroll and dose patients in two global Phase III clinical trials with its product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections (abSSSI). Dalbavancin is an intravenous antibiotic product candidate designed for once-weekly dosing. In addition to abSSSI, the Company focuses on the development of dalbavancin for additional indications, including osteomyelitis, diabetic foot infection and pneumonia.

As of December 31, 2011, Dalbavancin had already completed three Phase III clinical trials, in which more than 1,000 patients in total received dalbavancin. Dalbavancin achieved its primary efficacy endpoint of non-inferiority in each of these three completed Phase III clinical trials when compared to linezolid, cefazolin or vancomycin, three of the standard-of-care agents for uncomplicated skin and skin structure infections (uSSSI), and complicated skin and skin structure infections (cSSSI). Its two ongoing Phase III clinical trials are designed to compare dalbavancin to vancomycin, with an option to switch to oral linezolid, under the new FDA draft guidance.

The Company competes with Pfizer, Cubist Pharmaceuticals, Inc., Theravance, Inc., Forest Laboratories, Inc., Sanofi-Aventis Ltd., The Medicines Company, Trius Therapeutics, Inc., Cempra, Inc., Rib-X Pharmaceuticals, Inc., Paratek Pharmaceuticals, Inc., Nabriva Therapeutics AG, Tetraphase Pharmaceuticals, Inc. and Furiex Pharmaceuticals, Inc.

Advisors' Opinion:
  • [By Bob's Stocks]

    Durata Therapeutics (DRTX) is developing Dalbavancin, a once a week, intravenous antibiotic product candidate, for the treatment of patients with acute bacterial skin and skin structure infections, or ABSSSI. The company is expected to file a NDA (New Drug Application) at any moment and MAA (Marketing Authorization Application) at the end of 2013.

  • [By Lisa Levin]

    Durata Therapeutics (NASDAQ: DRTX) shares climbed 5.30% to $14.18. The volume of Durata Therapeutics shares traded was 861% higher than normal. The FDA Advisory Committee unanimously recommended the approval of Durata's Dalvance.

Top 10 Performing Companies To Own For 2015: Twin Butte Energy Ltd (TBTEF.PK)

Twin Butte Energy Ltd. (Twin Butte) is a Canada-based junior oil and gas exploration and production company. The Company is engaged in the acquisition of, exploration for and the development and production of petroleum and natural gas properties in Western Canada. During the year ended December 31, 2011, it drilled a total of 125 (80.9 net) wells. Its Frog Lake property is located approximately 75 kilometers northwest of Lloydminster with lands. Its Freemont area is located 60 kilometers southeast of Lloydminster. During 2011, Twin Butte drilled 11 gross wells in Plains region. Production from its west central Alberta region was approximately 1,545 barrels of oil equivalent per day during 2011. Production from its Deep Basin region was approximately 593 barrels of oil equivalent per day during 2011. Effective September 30, 2013, the Company disposed a non-core, west central Alberta, gas asset. In November 2013, the Company acquired Black Shire Energy Inc. Advisors' Opinion:
  • [By MLP Trader]

    Here are the current top five companies in the list:

    CompanySymbolEV/BOEPD/NetbackPrice/NAVEV/DACFPinecrest(PNCGF.PK)53564%4.0XLightstream(LSTMF.PK)131753%4.5XNovus(NOVUF.PK)133290%4.1XZargon(ZARFF.PK)138664%5.6XTwin Butte(TBTEF.PK)155885%5.5X

    Of the larger companies, one that remains obstinately near the top of the list is Lightstream . Lightstream trades at 40% of its book value and a whopping 13.4% yield.

Top 10 Performing Companies To Own For 2015: NPS Pharmaceuticals Inc.(NPSP)

NPS Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for gastrointestinal and endocrine disorders, and various medical needs. The company?s primary clinical programs include two therapeutic peptides to restore or replace biological functions comprising GATTEX, a Phase 3 clinical trial product for short bowel syndrome; and Natpara, a recombinant human parathyroid hormone 1-84, which is in Phase 3 clinical development trials. It also develops NPSP790 and NPSP795 calcilytic compounds that are in Phase I trials for the treatment of rare endocrine disorders. The company has collaborative and license agreements with Amgen Inc., Janssen, GlaxoSmithKline, Kyowa Hakko Kirin, and Nycomed Danmark ApS. NPS Pharmaceuticals, Inc. was founded in 1986 and is based in Bedminster, New Jersey.

Advisors' Opinion:
  • [By Jesse Solomon]

    NPS Pharmaceuticals (NPSP), for example, created a drug for treating short bowel syndrome. And Hyperion Therapeutics (HPTX) is developing a drug for hepatic encephalopathy, a decline of brain function that according to the National Institute of Health occurs when the liver is no longer able to remove toxins from the blood. Those stocks are up 20% and 40%, respectively, this year.

  • [By Keith Speights]

    Two high-flying biotech stocks of late are NPS Pharmaceuticals (NASDAQ: NPSP  ) and Regeneron Pharmaceuticals (NASDAQ: REGN  ) . Both have had great results over the past month.

Top 10 Performing Companies To Own For 2015: Albany Molecular Research Inc.(AMRI)

Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States, Europe, and Asia. The company offers a range of drug discovery services, including assay development and design, screening, screening library, natural product, medicinal chemistry, computer-aided drug discovery, in vitro ADMET, and bioanalytical services. It also provides chemical development services consisting of process research and development, custom synthesis, process safety assessment, scale-up capabilities, high potency and controlled substances, analytical services, preformulation services and physical characterization, preparative chromatography, IND support services, fermentation development and optimization, and building blocks collection and database services. In addition, the company offers chemical synthesis and manufacturing services. It manufactures active pharmaceutical ingredients (APIs)and advanced intermediate s. Further, the company provides contract manufacturing services in sterile syringe and vial filling for small molecule drug products and biologicals. Additionally, it offers formulation services, including neat API or pharmaceutical blend in capsules; PIB for solution and suspension; blending and sieving; milling; tableting; rheology; roller compaction; wet granulation; and fluid bed processing, including wurster coating; and associated analytical testing services for dosage formulation products, as well as provides analytical services, such as impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; stability services; analytical and preparative supercritical fluid chromatography; preparative chromatography; good laboratory practices bioanalytical services; and regulatory support/quality assurance services. The company was founded in 1991 and is based in Albany, New York.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Among the sector stocks, Albany Molecular Research (NASDAQ: AMRI) was down more than 13 percent, while Sangamo Biosciences (NASDAQ: SGMO) tumbled around 6 percent.

  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Healthcare stocks gained Wednesday, with Senomyx (NASDAQ: SNMX) leading advancers after the company announced a research agreement with PepsiCo (NYSE: PEP). Among the leading sector stocks, gains came from Pernix Therapeutics Holdings (NASDAQ: PTX), Albany Molecular Research (NASDAQ: AMRI) and Gentiva Health Services (NASDAQ: GTIV).

Top 10 Performing Companies To Own For 2015: Performant Financial Corp (PFMT)

Performant Financial Corporation (Performant), incorporated on October 8, 2003, provide technology-enabled recovery and related analytics services in the United States. The Company�� services help identify and recover delinquent or defaulted assets and improper payments for both government and private clients in a broad range of markets. The Company provides its services on an outsourced basis, where the Company handles many or all aspects of its clients��recovery processes. The Company derives its revenues from services for clients in a range of different markets. These markets include student lending and healthcare, as well as its other markets, which include delinquent state taxes and federal Treasury and other receivables. The Company�� clients include 12 of the 32 public sector participants in the student loan industry. In February 2012, it purchased a perpetual software license and computer equipment from HOPS, Inc.

Student Lending

The Company derives its revenues from the recovery of student loans. These revenues are contract-based and consist primarily of contingency fees based on a specified percentage of the amount the Company enables its clients to recover. The Company engages subcontractors to assist in the recovery of a portion of the client�� portfolio. It also receives success fees for the recovery of loans under Master Service Agreements (MSAs) and its revenues under MSA arrangements include fees earned by the activities of its subcontractors. The Company uses its technology to identify, track and communicate with defaulted borrowers on behalf of its clients to implement suitable recovery programs for the repayment of outstanding student loan balances.

The Company�� client�� contract with it to provide recovery services for large pools of student loans generally representing a portion of the total outstanding defaulted balances they manage, which they provide to us as placements on a periodic basis. The Company also restructures and r! ecovers student loans issued directly by banks to students outside of federal lending programs.

Healthcare

The Company derives revenues from the healthcare market primarily from its Recovery Audit Contractor (RAC), contract, under, which it is a prime contractor responsible for detecting improperly paid Part A and Part B Medicare claims in 12 states in the Northeastern United States. Revenues earned under the RAC contract are driven by the identification of improperly paid Medicare claims through both automated and manual review of such claims. The Company outsourced certain aspects of its healthcare recovery process to three different subcontractors.

Other

The Company derives revenues from the recovery of delinquent state taxes, and federal Treasury and other receivables, default aversion services for certain clients, including financial institutions and the licensing of hosted technology solutions to certain clients. For its hosted technology services, the Company licenses its system and integrates its technology into its clients��operations, for which it is paid a licensing fee. The Company�� revenues for these services include contingency fees, fees based on dedicated headcount to its clients and hosted technology licensing fees. The federal agency market consists of government debt subrogated to the Department of the Treasury.

For state and municipal tax authorities, the Company analyzes a portfolio of delinquent tax and other receivables placed with the Company, develop a recovery plan and execute a recovery process designed to maximize the recovery of funds. In some instances, it has also run state tax amnesty programs, which provide one-time relief for delinquent tax obligations, and other debtor management services for its clients. For the Department of the Treasury, it recovers government debt subrogated to it by numerous different federal agencies. The placements it has provided represent a mix of commercial and individual oblig! ations.

Data Management Expertise

The Company�� platform manages and stores large amounts of data throughout the workflow process. This includes both data it has compiled, as well as third-party data.

Data Analytics Capabilities

The Company�� data analytics capabilities screen and allocate massive volumes of recovery inventory. Upon receipt of each placement of student loans, the Company utilize its algorithms to assist its in determining the recovery process and the optimal allocation of recovery specialist resources for each loan. In the healthcare market, the Company analyze millions of Medicare claims to find potential correlations between claims data and improper payments.

Workflow Processes

The Company refers to the patented technology that supports its workflows as Smart Bins. The Company�� workflow processes integrate a range of functions that encompass each stage of a recovery process.

The Company competes with Health Management Systems, Inc., Connolly Consulting, Inc. and CGI Group.

Advisors' Opinion:
  • [By Roberto Pedone]

    Performant Financial (PFMT) provides technology-enabled recovery and related analytics services in the U.S. This stock closed up 6.9% at $11.84 in Friday's trading session.

    Friday's Volume: 310,000

    Three-Month Average Volume: 261,916

    Volume % Change: 60%

    From a technical perspective, PFMT soared higher here right off both its 200-day moving average of $11.02 and its 50-day moving average at $11.06 with decent upside volume. This move is quickly pushing shares of PFMT within range of triggering a major breakout trade. That trade will hit if PFMT manages to take out some near-term overhead resistance levels at $12.47 to $13.26 with high volume.

    Traders should now look for long-biased trades in PFMT as long as it's trending above its 200-day at $11.02 and then once it sustains a move or close above those breakout levels with volume that's near or above 261,916 shares. If that breakout hits soon, then PFMT will set up to re-test or possibly take out its all-time high at $14.09. Any high-volume move above $14.09 will then give PFMT a chance to trend north of $15.

  • [By Magic Diligence]

    Much of United Online's appeal was due to its over 4% dividend yield, but the company announced in late January that it would be discontinuing its dividend to focus on growth initiatives. This follows itsNovember spin-off of FTD, which leaves United with 3 cash producing but declining businesses: Classmates.com, NetZero, and Juno. NetZero Mobile Broadband is an interesting product but one with a lot of competition from the carriers. Frankly, the dividend has been the main attraction for some time, and without it this is a declining company with a fair bit of debt. That does not make for the most attractive option. PASS.

    Performant Financial (PFMT) - down 28.1%

    Performant earns fees for collecting delinquent student loans (about 60% of the business) and providing recovery services for improper Medicare payments (close to 30%). The recent sell-off in the stock seems due to comments from Sallie Mae regarding lower rehabilitation fees paid to Guarantee Agencies, which investors expect to "trickle down" to service providers like PFMT. The stock has been sold off dramatically on these assumptions. We should know more when the company reports earnings in the coming weeks, but this is one worth looking at more closely - the firm has been growing revenue at 30%+ rates. WORTHY OF CONSIDERATION.

Top 10 Performing Companies To Own For 2015: Jinzanghuang Tibet Pharmaceuticals Inc (JZHG)

Jinzanghuang Tibet Pharmaceuticals, Inc. distributes Tibetan pharmaceutical and nutraceutical products in the People�� Republic of China (PRC) through Leling Jinzanghuang Biotech Co., Ltd. (Leling JZH). The Company, through its wholly owned subsidiary, Tibet Medicine, Inc., owns 100% of Beijing Taibodekang Consulting Co., Ltd. (Beijing Taibodekang), a wholly foreign owned entity. Beijing Taibodekang had entered into four agreements with Leling Jinzanghuang Biotech Co., Ltd. (Leling Jinzanghuang) and with the equity owners in Leling Jinzanghuang. Collectively, the agreements provide Beijing Taibodekang exclusive control over the business of Leling Jinzanghuang. Leling Jinzanghuang engages in the distribution of the pharmaceutical and nutraceutical products that Tibetans have used for centuries to treat diseases and facilitate health. The distributed products are classified by Leling Jinzanghuang in three major categories: pharmaceuticals, therapeutic supplements, and dietary supplements.

The 13 Tibetan health products that Leling Jinzanghuang distributes are among those Tibetan medicines made with modern drug manufacturing techniques. The manufacturing equipment and techniques used by its supplier are certified under China�� national standards of Good Manufacturing Practice (GMP), and are in compliance with applicable regulations of the Chinese Food and Drug Administration (SFDA), which regulates both the pharmaceutical and the nutraceutical industries in China.

Ying Huang Tablet

Ying Huang Tablet is one the two pharmaceutical products marketed by Leling Jinzanghuang that been approved by SFDA. The effective ingredients in the Ying Huang Tablet are extracts from the honeysuckle and the Huangqin herb. It can be used to treat upper respiratory infections including pharyngitis, encephalitis and conjunctivitis. It can also be used to reduce inflammation and relieve pain.

San Qi Capsules

San Qi Capsules is a dietary supplements certified! by SFDA. San Qi Capsules lower blood lipid and cholesterol levels. Thus they can be used as a precautionary therapy to prevent cardiovascular diseases, including coronary heart disease, heart angina and stroke. In addition, the San Qi Capsules enhance immune system functions, which may help in the prevention of cancer.

Foshou Capsules

Foshou Capsules is a Tibetan nutraceutical. The effective ingredients, Xue Yu, Dongchong Xiacao, Fozhang, and Ginseng, are extracts of several plants and animals that are native to the Tibet Plateau.

Bai He Capsules

Bai He Capsules is a Tibetan dietary supplement. The effective ingredients consist of Baihe, Fozhang Ginseng and Himalayan purple jasmine. The Bai He Capsules are used to treat male erectile dysfunction and other sexual dysfunction problems.

The Company competes with Jingqiu Tibetan Medicine, Jinhe Tibetan Medicine and Tibetan Pharmaceutical Factory, Tibet Cheezheng Tibetan Medicine and Niemula Tibet Medicine.

Advisors' Opinion:
  • [By Peter Graham]

    Small cap medical technology stock Sanomedics International Holdings (OTCMKTS: SIMH) recently completed financing and an acquisition while JinZangHuang Tibet Pharmaceuticals, Inc (OTCMKTS: JZHG) surged 48.28% on Friday. However, that�� only part of the story as one of these stocks has been the subject of paid promotions while the other has no new news for investors. So are either of these small cap stocks the cure for any portfolio pains you may be suffering from? Here is a quick reality check:

Top 10 Performing Companies To Own For 2015: IDT Corp (IDT)

IDT Corporation (IDT), incorporated on March 15, 1996, is a multinational holding company with operations primarily in the telecommunications industry. The Company operates in two segments: Telecom Platform Services and Consumer phones Services, which comprise its IDT Telecom division. Telecom Platform Services provides telecommunications services, including prepaid and rechargeable calling products and international long distance traffic termination, as well as various payment services. Consumer Phone Services provides consumer local and long distance services in the United States. All other segments include Zedge Holdings, Inc. (Zedge), which owns and operates an on-line platform, including Android app, that allows users to share and obtain content to personalize mobile phones and tablets; Fabrix T.V., Ltd. (Fabrix), a software development company specializing in cloud-based video processing, storage and delivery; IDT Spectrum, which holds, leases and sells fixed wireless spectrum; Innovative Communications Technologies, Inc. (ICTI), which holds intellectual property primarily related to voice over Internet protocol (VoIP), technology and the licensing and other businesses related to this intellectual property; the Company's real estate holdings, and other smaller businesses. On October 28, 2011, the Company completed the Genie Energy spin-off. In July 2013, Straight Path Communications Inc announced its spin-off from IDT Corporation.

Telecom Platform Services

IDT markets and distributes multiple communications and payment services across four business categories, including retail communications, wholesale termination services, payment services and hosted platform solutions. Retail Communications provides international long-distance calling products primarily to immigrant communities worldwide, with markets in the United States and Europe. These products include the Company's Boss Revolution Pinless product (an international calling service sold through the Boss Revolution ! payment platform), as well as many of its disposable calling card brands, including Boss, La Leyenda and Feliz, and mobile apps, including PennyTalk. Wholesale Termination Services is a global telecom carrier, terminating international long distance calls around the world for Tier 1 fixed line and mobile network operators, as well as other aggregators through the Company's network of 800-plus carrier interconnects. Payment Services provides payment offerings, such as international mobile top-up, or IMTU, as well as gift cards in both the United States and Europe. IMTU enables customers to purchase minutes for a prepaid mobile telephone in another country. IMTU is available in both traditional cards, as well as on the Company's Boss Revolution payment platform. Payment Services also includes reloadable prepaid debit cards and bank identification number (BIN) sponsorship services offered in Europe by IDT Financial Services through the Company's Gibraltar-based bank. Hosted Platform Solutions provides customized communications services that leverage the Company's networks, platforms and/or technology to cable companies and other operators.

The Company�� Boss Revolution payment platform is an online portal that can be accessed via a regular Web browser and utilized to sell a range of the Company's products and services. During the fiscal year ended July 31, 2012, the Company added domestic mobile top-up (DMTU) offerings. The Company sells its traditional calling cards under the La Leyenda, Boss, Playball, GOOOL, RED, Feliz, PT-1 and PennyTalk brand names, among others, providing telephone access to more than 230 countries and territories. As of July 31, 2012, IDT sold more than 1,000 different calling cards in the United States and more than 800 different cards abroad, with specific cards featuring favorable rates to specific international destinations. The Company's calling cards are marketed primarily to the ethnic and immigrant communities in the United States, Europe, Asia, Latin America! and Afri! ca.

Consumer Phone Services

The Company provides its bundled local/long distance phone service in 11 states, marketed under the brand name IDT America. The Company's bundled local/long distance service, offered predominantly to residential customers, includes unlimited local, regional toll and domestic long distance calling and popular calling features. A second plan is available, providing unlimited local service with the Company's long distance included for as low as 3.9 cents per minute. IDT also offers stand-alone long distance service throughout the United States. As of July 31, 2012, the Company had approximately 10,500 active customers for its bundled local/long distance plans and approximately 45,200 customers for its long distance-only plans.

The Company competes with AT&T,Verizon, InComm, Blackhawk Network and Coinstar.

Advisors' Opinion:
  • [By Seth Jayson]

    IDT (NYSE: IDT  ) reported earnings on June 6. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended April 30 (Q3), IDT met expectations on revenues and beat expectations on earnings per share.

  • [By Monica Gerson]

    IDT (NYSE: IDT) is projected to report its Q4 earnings at $0.28 per share on revenue of $397.40 million.

    Xyratex (NASDAQ: XRTX) is expected to post its Q3 earnings at $0.05 per share on revenue of $209.31 million.

No comments:

Post a Comment